Halozyme Therapeutics Inc
NASDAQ:HALO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
US |
|
Airbus SE
PAR:AIR
|
NL |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
Danaos Corp
NYSE:DAC
|
GR |
|
A
|
Allianz SE
F:ALV
|
DE |
|
Cass Information Systems Inc
NASDAQ:CASS
|
US |
|
M
|
Marks and Spencer Group PLC
OTC:MAKSF
|
UK |
|
Driven Brands Holdings Inc
NASDAQ:DRVN
|
US |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
Ubiquiti Inc
NYSE:UI
|
US |
Intrinsic Value
The intrinsic value for Halozyme Therapeutics Inc (HALO) under the Base Case is hidden
USD.
Compared with the current market price of 71.585 USD, the stock appears hidden
.
HALO looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether HALO usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Halozyme Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Halozyme Therapeutics Inc
Earnings Waterfall
Halozyme Therapeutics Inc
The intrinsic value for Halozyme Therapeutics Inc (HALO) under the Base Case is hidden USD.
Compared with the current market price of 71.585 USD, the stock appears hidden.
